Andrew J Doyle

Consultant Haematologist
Haemostasis & Thrombosis Centre, St Thomas’ Hospital, London, UK
London, England, United Kingdom

Presentation(s):

• PB0133 - Identification of FVIII inhibitors by anti-FVIII ELISA assay and Bethesda assays in tandem to identify anti-Factor VIII inhibitors

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0144 - Use of an FVIIa antithrombin activity assay to determine the incidence of antithrombin deficiency in a high-risk population.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 26.3 - PLASMIC score to differentiate TTP from other causes of microangiopathic haemolytic anaemia

  Sunday, June 23, 2024
  15:15 – 15:30 ICT

• PB0956 - The efficacy and safety of direct oral anticoagulants (DOACs) in the secondary prevention of VTE in individuals with inherited antithrombin deficiency: a cohort study from a tertiary referral centre

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1250 - Haemostatic Management of a Moderate Haemophilia B (MHB) Patient with respiratory failure through VV-Extracorporeal Membrane Oxygenation (ECMO)

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT